8-11260256-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000443854.2(LINC00529):​n.136+7533C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.205 in 151,880 control chromosomes in the GnomAD database, including 3,951 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3951 hom., cov: 32)

Consequence

LINC00529
ENST00000443854.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.274

Publications

4 publications found
Variant links:
Genes affected
LINC00529 (HGNC:15544): (long intergenic non-protein coding RNA 529)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000443854.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.336 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000443854.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LINC00529
NR_170283.1
n.558+7533C>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LINC00529
ENST00000443854.2
TSL:2
n.136+7533C>G
intron
N/A
LINC00529
ENST00000711291.1
n.214+7021C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.205
AC:
31137
AN:
151762
Hom.:
3930
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.341
Gnomad AMI
AF:
0.0526
Gnomad AMR
AF:
0.294
Gnomad ASJ
AF:
0.211
Gnomad EAS
AF:
0.141
Gnomad SAS
AF:
0.154
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.124
Gnomad OTH
AF:
0.228
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.205
AC:
31197
AN:
151880
Hom.:
3951
Cov.:
32
AF XY:
0.205
AC XY:
15228
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.341
AC:
14126
AN:
41424
American (AMR)
AF:
0.294
AC:
4492
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.211
AC:
731
AN:
3472
East Asian (EAS)
AF:
0.141
AC:
729
AN:
5176
South Asian (SAS)
AF:
0.154
AC:
738
AN:
4804
European-Finnish (FIN)
AF:
0.130
AC:
1368
AN:
10518
Middle Eastern (MID)
AF:
0.282
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
0.124
AC:
8397
AN:
67908
Other (OTH)
AF:
0.230
AC:
485
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1214
2427
3641
4854
6068
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0684
Hom.:
77
Bravo
AF:
0.228
Asia WGS
AF:
0.180
AC:
621
AN:
3462

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
2.5
DANN
Benign
0.55
PhyloP100
0.27

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2736376;
hg19: chr8-11117765;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.